SCHEMBL2726293

SCHEMBL2726293

CCCCCCCCc1ccc(CCCO)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.69
ADRA2A P08913 2/20 0.69
ADORA3 P0DMS8 2/20 0.69
TACR2 P21452 2/20 0.69
SLC6A2 P23975 2/20 0.69
SLC6A4 P31645 2/20 0.69
SLC6A3 Q01959 2/20 0.69
ALDH1A1 P00352 2/20 0.69
LMNA P02545 2/20 0.69
CYP3A4 P08684 2/20 0.69
KDM4E B2RXH2 1/20 0.69
SHBG P04278 1/20 0.69
TP53 P04637 1/20 0.69
HSPD1 P10809 1/20 0.69
ADRB3 P13945 1/20 0.69
HTR2C P28335 1/20 0.69
HSPE1 P61604 1/20 0.69
HIF1A Q16665 1/20 0.69
TST Q16762 1/20 0.69
HSD17B10 Q99714 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6285688 1.00 ESR1 (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL6282873 1.00 ESR1 (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL6287871 0.98 ALDH1A1 (0.65) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL18533218 0.95 LMNA (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL879252 0.95 LMNA (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL8496112 0.95 LMNA (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL6270009 0.95 LMNA (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL10929763 0.95 LMNA (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL15922494 0.95 LMNA (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL9512491 0.95 LMNA (0.69) ESR1ADRA2AADORA3TACR2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3092222-A1 IMPROVED FINGOLIMOD PROCESS Emcure Pharmaceuticals Limited (IN) 2016-11-16 EP disclosed
WO-2015107548-A1 IMPROVED FINGOLIMOD PROCESS EMCURE PHARMACEUTICALS LIMITED (IN) 2015-07-23 WO disclosed
WO-2014118556-A2 SELECTIVE INHIBITORS AND ALLOSTERIC ACTIVATORS OF SPHINGOSINE KINASE RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2014-08-07 WO disclosed
EP-2632889-A2 INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF FINGOLIMOD Mapi Pharma Limited (IL) 2013-09-04 EP disclosed
WO-2012056458-A2 INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF FINGOLIMOD MAPI PHARMA LTD. (IL) 2012-05-03 WO disclosed